Top Gene editing Stocks in United States
Browse the largest United States companies in the world ranked by their Market Capitalization. Global Gene editing Companies in United States market cap is $250.13B.
19 Dec 2024, 19:18 UTC
Companies: 12
🇺🇸1 |  | $447.50 | -4.63% | 115.32B | 10.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸2 |  | $714.62 | -3.43% | 76.56B | -18.23% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸3 |  | $134.03 | -6.35% | 21.28B | -2.80% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸4 |  | $146.79 | -2.56% | 21.24B | -43.01% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸5 |  | $26.45 | -7.45% | 2.16B | -1.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸6 |  | $8.41 | -6.24% | 1.62B | 513.87% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸7 |  | $12.02 | -8.45% | 1.08B | -60.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $5.09 | -9.27% | 409.36M | -63.17% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸9 |  | $44.46 | -10.65% | 356.19M | -5.69% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸10 |  | $2.64 | -9.28% | 256.94M | -70.10% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸11 |  | $1.35 | -11.51% | 109.85M | -86.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸12 |  | $4.03 | -9.64% | 81.31M | -32.83% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
